Target intelligence / Profile preview

Mumps virus internal proteins (MuV internal proteins)

Target
MuV internal proteins
Molecular classification
Enzyme, Transcription factor, Viral structural protein, Viral non-structural protein, Other
01

Overview

The internal proteins of the Mumps virus (MuV), a member of the Paramyxoviridae family, include the nucleocapsid (N), phosphoprotein (P), large (L) polymerase, matrix (M), and the non-structural V and I proteins (UniProt: P11214, P06940). These proteins are essential for the viral life cycle, facilitating genome encapsidation, RNA-dependent RNA replication, transcription, and viral assembly (PubMed: 25653450). The L and P proteins form the polymerase complex responsible for synthesizing viral mRNA and genomic RNA, while the N protein protects the RNA genome from host cell nucleases and serves as a template for replication (PubMed: 17223310). The M protein is critical for orchestrating virus assembly and budding at the host cell plasma membrane (PubMed: 22114333). Furthermore, the V protein acts as a potent interferon antagonist by targeting STAT proteins for proteasomal degradation, thereby subverting the host's innate immune response (PubMed: 11435588). While current clinical management relies on vaccination, these internal proteins are primary targets for developing direct-acting antivirals, including polymerase inhibitors like ribavirin and favipiravir, which aim to halt viral replication (PubMed: 15652225, PubMed: 24434254).

Other names
Mumps orthorubulavirus internal proteinsMuV N, P, L, M, V, and I proteinsMumps virus nucleocapsid proteinMumps virus phosphoproteinMumps virus large proteinMumps virus matrix proteinMumps virus V proteinMumps virus I protein
02

Mechanism of action

Inhibition of the viral RNA-dependent RNA polymerase (RdRp) complex, disruption of the interaction between the nucleocapsid and polymerase, and interference with viral assembly and budding processes.

03

Biological functions

Immune responseViral replicationViral transcriptionViral assemblyGenome encapsidationOther
04

Disease associations

Infection
05

Safety considerations

Development of antiviral resistancePotential for mutagenicity with nucleoside analoguesOff-target effects on host cellular polymerasesSystemic toxicity
06

Interacting drugs

Ribavirin

2 more in the full profile.

07

Biomarkers

Mumps virus RNA (RT-qPCR)Nucleocapsid (N) protein levelsSTAT1/STAT2 degradation levelsViral load

Beyond the preview

Go deeper on Mumps virus internal proteins (MuV internal proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mumps virus internal proteins (MuV internal proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call